Tumor necrosis factor-induced E-selectin expression on vascular endothelial cells

Critical Care Medicine

Volumn 24, Issue 9, 1996, Pages 1543-1546

  Gedeit, Rainer G ^a,b  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

adhesion molecules; critical illness; cytokines; E selectin; endothelium; inflammation; monoclonal antibodies; tumor necrosis factor; tumor necrosis factor receptor

Indexed keywords

CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIBODY BLOOD LEVEL; ARTICLE; CRITICAL ILLNESS; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0029832409     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199609000-00019     Document Type: Article

References (26)

1. Heller RA, Kroenke M: Tumor necrosis actor receptor-mediated signaling pathways. J Cell Biol 1994; 126:5-9
2. Dembic Z, Loetscher H, Gubler U, et al: Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 1990; 2: 231-236
3. Jacobsen FW, Rothe M, Rusten L, et al: Role of the 75-kDa tumor necrosis factor receptor: Inhibition of early hematopoiesis. Proc Natl Acad Sci U S A 1994; 91:10695-10699
4. Tartaglia LA, Rothe M, Hu YF, et al: Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993; 73:213-216
5. Heller RA, Song K, Fan N: Cytotoxicity by tumor necrosis factor is mediated by both p55 and p70 receptors. Cell 1993; 73:216
6. Heller RA, Song K, Fan N, et al: The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 1992; 70:47-56
7. Bigda J, Beletsky I, Brakebusch C, et al: Dual role of the p75 tumor necrosis factor receptor in TNF cytotoxicity. J Exp Med 1994; 180:445-460
8. Mengazzi R, Cramer R, Partriarca P, et al: Evidence that TNF-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor. Blood 1994; 4:287-293
9. Medvedev AE, Sundan A, Espervik T: Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur J Immunol 1994; 24:2842-2849
10. Barbara JAJ, Smith WB, Gamble JR, et al: Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor and p75 receptor-selective TNF-alpha mutants. EMBO J 1994; 13: 843-850
11. Broudy VC, Harlan JM, Adamson JW: Disparate effect of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion expression by cultured human endothelial cells. J Immunol 1987; 138:4298-4302
12. Shalaby MR, Sundan A, Loetscher H, et al: Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J Exp Med 1990; 172: 1517-1520
13. Kuijpers TW, Hakkert BC, Hoogerwerf M, et al: Role of endothelial leukocyte adhesion molecule-1 and platelet activating factor in neutrophil adherence to IL-1-prestimulated endothelial cells. J Immunol 1991; 147:1369-1376
14. Talbott GA, Sharar SR, Harlan JM, et al: Leukocyte-endothelial interactions and organ injury: The role of adhesion molecules. New Horiz 1994; 2:545-554
15. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994; 84:2068-2101
16. Mackay F, Loetscher H, Steuber D, et al: Tumor necrosis factor-alpha-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 1993; 177:1277-1286
17. Paleolog EM, Delasalle SAJ, Buurman WA, et al: Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood 1994; 84:2578-2590
18. Jaffe EA, Nachman RL, Becker CG, et al: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2755
19. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994; 84:2068-2101
20. Banner DW, D'Arcy A, Janes W, et al: Crystal structure of the soluble human 55kd TNF receptor-human TNF-beta complex: Implications for TNF receptor activation. Cell 1993; 73:431-445
21. Thoma B, Grell M, Pfizenmaier K, et al: Identification of a 60-kD tumor necrosis factor receptor as the major signal transducing component in TNF responses. J Exp Med 1990; 172:1019-1023
22. Chambaut-Guerin AM, Guerrier M, Thmopoulos P: Role of the 75 kD-and 55kD-receptors in tumour necrosis factor mediated cytotoxicity and its regulation by dexamethasone and by 1,25-dihydroxy-vitamin D3 in U937 cells. Eur Cytokine Net 1993; 4:285-292
23. Chambaut-Guerin AM, Thmopoulos P: Regulation by dexamethasone and 1,25-dihydroxy-vitamin D3 of the 75 kD-type A tumor necrosis factor receptor surface expression and mRNA level in U937 cells. Eur Cytokine Net 1991; 5:355-360
24. Risau W: Differentiation of endothelium. FASEB J 1995; 9:926-933
25. Carlos TM, Harlan: Leukocyte-endothelial interactions. Blood 1994; 84: 2068-2101
26. Tedder TF, Steeber DA, Chen A, et al: The selectins: Vascular adhesion molecules. FASEB J 1995; 9:866-873